Cocrystal Pharma, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 5.19 million compared to USD 4.21 million a year ago. Basic loss per share from continuing operations was USD 0.64 compared to USD 0.52 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.57 USD | -2.48% | +1.29% | -8.84% |
05-01 | Cocrystal Pharma, Inc. Announces Completion of Enrollment of 78 Subjects | CI |
03-28 | Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.84% | 15.97M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- COCP Stock
- News Cocrystal Pharma, Inc.
- Cocrystal Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023